Urology · Cranford, NJ
NPI
1144219791
Since 2005
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
570 South Ave E Bldg A
Cranford, NJ, 07016
Phone (908) 603-4200
Groups this clinician bills Medicare through
Medicare paid, 2024
$585K
20,872 services
Medicare patients, 2024
955
Average age 76
Drug cost, 2024
$1.0M
3,933 prescriptions
Company payments, 2025
$1,310
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark I Miller was code J0585 (injection, onabotulinumtoxina, 1 unit), 2,400 times for 18 patients. In total Mark I Miller billed 20,872 services in 111 codes, and Medicare paid $585K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 2,400 | 18 | $4.98 | $12K |
| 81002 Clinical Chemistry | Office | 1,811 | 836 | $3.39 | $6,146 |
| 99214 Office E&M - Established | Office | 1,041 | 571 | $98.65 | $103K |
| 99213 Office E&M - Established | Office | 792 | 515 | $67.79 | $54K |
| 51798 Ultrasound - Nonspecific | Office | 706 | 473 | $9.04 | $6,385 |
| 36415 Venipuncture Blood Collection | Office | 605 | 435 | $8.59 | $5,199 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 575 | 450 | $13.69 | $7,871 |
| 51741 Test - Miscellaneous | Office | 555 | 381 | $10.56 | $5,861 |
| 55899 Other Organ Systems | Office | 297 | 236 | $145.91 | $43K |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 277 | 239 | $46.32 | $13K |
| 84153 Clinical Chemistry | Office | 235 | 225 | $17.87 | $4,199 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 204 | 28 | $137.15 | $28K |
| 76857 Ultrasound - Abdomen and Pelvis | Office | 157 | 155 | $37.83 | $5,940 |
| 96402 Chemotherapy Administration | Office | 151 | 32 | $27.95 | $4,221 |
| 99204 Office E&M - New | Office | 112 | 112 | $114.72 | $13K |
By year: 2022 $574K for 23,363 services; 2023 $653K for 27,353 services; 2024 $585K for 20,872 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 1,811 | 836 | $3.39 | $6,146 |
| 36415 Venipuncture Blood Collection | 605 | 435 | $8.59 | $5,199 |
| 84153 Clinical Chemistry | 235 | 225 | $17.87 | $4,199 |
| 87086 Bacterial Culture | 78 | 56 | $7.91 | $617 |
| 87088 Bacterial Culture | 69 | 52 | $7.93 | $547 |
| 87186 General Laboratory | 43 | 29 | $8.48 | $365 |
| 87077 Bacterial Culture | 42 | 28 | $7.92 | $333 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark I Miller prescribed most often to Medicare patients was Tamsulosin Hcl, with 968 prescriptions and refills. In total Mark I Miller wrote 3,933 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 968 | 2,781 | 335 | $19K |
| Dutasteride Generic | 411 | 1,140 | 137 | $14K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 333 | 888 | 109 | $11K |
| Finasteride Generic | 267 | 777 | 80 | $4,551 |
| Myrbetriq Mirabegron | 222 | 515 | 70 | $222K |
| Dutasteride-Tamsulosin Dutasteride/Tamsulosin Hcl | 213 | 597 | 73 | $46K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 176 | 453 | 59 | $5,655 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 169 | 169 | 132 | $1,608 |
| Ciprofloxacin Hcl Generic | 151 | 151 | 119 | $651 |
| Gemtesa Vibegron | 132 | 328 | 45 | $152K |
| Cephalexin Generic | 119 | 265 | 58 | $1,435 |
| Levofloxacin Generic | 89 | 89 | 65 | $236 |
| Silodosin Generic | 80 | 235 | 23 | $8,002 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 77 | 88 | 45 | $1,770 |
| Potassium Citrate Er Potassium Citrate | 42 | 121 | 18 | $4,672 |
Brand drugs: 478 claims; generic drugs: 3,439 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark I Miller $1,310 ($1,310 in general payments such as food, travel and fees) from 24 companies. The largest payer was Antares Pharma, Inc. with $173.
| Company | Payments | Amount |
|---|---|---|
| Antares Pharma, Inc. | 22 | $173 |
| Olympus America Inc. | 8 | $158 |
| Teleflex LLC TFX | 2 | $103 |
| Boston Scientific Corporation BSX | 4 | $83.12 |
| Seagen Inc. PFE | 1 | $78.99 |
| Astellas Pharma US Inc 4503.T | 4 | $69.08 |
| Verity Pharmaceuticals Inc. | 3 | $66.76 |
| Medtronic, Inc. MDT | 3 | $64.67 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $50.9 |
| Progenics Pharmaceuticals, Inc. | 2 | $48.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.